Blood News and Research

RSS

IQWiG identifies additional recommendations for diabetes mellitus type 2 DMP

On 3 January 2012, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with diabetes mellitus type 2.

4 Jan 2012

Shorter Chk1 protein neutralizes longer sibling to potentially benefit cancer patients

Scientists have found at least one instance when the smaller sibling gets to call the shots and cancer patients may one day benefit.

4 Jan 2012

Home-monitoring interventions may benefit patients with heart failure

Heart failure affects 5.8 million people in the U.S. alone and is responsible for nearly 1 million hospitalizations each year, most resulting from a build-up of body fluid in the lungs and other organs due to the heart's inability to pump effectively. The disease needs to be closely tracked in order to avoid such hospitalizations, and home-monitoring interventions may be especially useful, UCLA researchers say.

4 Jan 2012

Losartan may help prevent smoking-related COPD

Working with mice, scientists at Johns Hopkins have successfully used a commonly prescribed blood pressure medicine, losartan (Cozaar), to prevent almost all of the lung damage caused from two months of exposure to cigarette smoke. The treatment specifically targeted lung tissue breakdown, airway wall thickening, inflammation and lung over-expansion.

4 Jan 2012

Researchers identify candidate genes for histiocytoid cardiomyopathy

Researchers are closing in on a rare genetic disorder causing a heart condition in infants. Histiocytoid cardiomyopathy (HC) often causes sudden death before a child reaches 2 years of age. Gene analysis is helping to narrow the many theories surrounding the genetic basis of HC.

4 Jan 2012

Young stem/progenitor cells improve health and life of progeria mice

Mice bred to age too quickly seemed to have sipped from the fountain of youth after scientists at the University of Pittsburgh School of Medicine injected them with stem cell-like progenitor cells derived from the muscle of young, healthy animals.

4 Jan 2012

Researchers discover a way to make cigarette smoking less toxic

From a health care perspective, the best cigarette is no cigarette, but for the millions of people who try to quit smoking every year, researchers from Cornell University may have found a way to make cigarette smoking less toxic.

4 Jan 2012

Non-invasive test for early detection of fetal gender

A new research study published in the January 2012 edition of The FASEB Journal describes findings that could lead to a non-invasive test that would let expecting mothers know the sex of their baby as early as the first trimester.

4 Jan 2012

Mitochondrial dysfunction in tissue stem cells can cause aging-associated degeneration

Aging-related tissue degeneration can be caused by mitochondrial dysfunction in tissue stem cells. The research group of Professor Anu Suomalainen Wartiovaara at the University of Helsinki, with their collaborators in Max Planck Institute for Biology of Aging, Karolinska Institutet and University of Wisconsin, reported on the 3rd January in Cell Metabolism their results on mechanisms of aging-associated degeneration.

4 Jan 2012

Hydrogen sulfide decreases manufacture of kidney scarring matrix proteins

Hydrogen sulfide, a gas notorious for its rotten-egg smell, may have redeeming qualities after all. It reduces high glucose-induced production of scarring proteins in kidney cells, researchers from The University of Texas Health Science Center San Antonio report in the Journal of Biological Chemistry.

4 Jan 2012

Low T Center for testosterone replacement therapy opens new clinic in Denver

Low T Center is opening a new clinic at 12213 North Pecos, Westminster, Co., a suburb of Denver on Tuesday, January 3, 2012. This men's oriented clinic will provide testosterone replacement therapy in the form of testosterone injections for men around the ages of 40-60 years old.

4 Jan 2012

Viewpoints: Giving states responsibility for 'essential benefits'; The cost of proton beam treatment; Health spending in 2012

The Obama administration surprised supporters and critics when it decided to let states define the "essential health benefits" that must be provided to their citizens under health care reform. ... Federal health officials will need to monitor developments during the transition period to make sure consumers and employers can easily compare the benefit packages offered by private insurers.

3 Jan 2012

Vitamins and omega 3 fatty acids in blood could stave off dementia: Study

A new study has shown that higher blood levels of omega-3 fatty acids, vitamin B, vitamin C, vitamin D and vitamin E are associated with better mental functioning in the elderly.

3 Jan 2012

Many obese people in denial mode: Survey

According to a new survey only six per cent of overweight people believe they should be described as obese. Three quarters of those with an obese body mass index underestimated their weight category, according to the Yougov poll of 2,065 people.

3 Jan 2012

Hormone Adiponectin linked to dementia in women: Study

New research has shown that there may be a possible connection between a hormone found in body fat and the risk of dementia, adding to the growing evidence on the potential link between the condition and diabetes.

3 Jan 2012

Gestational diabetes along with poverty raises risk of ADHD in the child: Study

According to a new study pregnant mothers with gestational diabetes are more likely to have kids with attention deficit hyperactivity disorder. Additionally if they have a poorer socioeconomic status, the child is 14 times more likely to be diagnosed with the behavioral disorder, researchers at Queens College and Mount Sinai School of Medicine found.

3 Jan 2012

TrovaGene acquires license to mutations of SF3B1 splicing factor in CLL

TrovaGene, Inc., a developer of trans-renal molecular diagnostics, today announced that it has obtained an exclusive worldwide license to mutations of the SF3B1 splicing factor, which have been shown to be associated with disease progression and chemotherapy response in patients suffering from chronic lymphocytic leukemia.

3 Jan 2012

Ampio completes enrollment phase of Australian Ampion In Knee trials

Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, today announced that it is has completed the expanded patient enrollment phase of its Ampion In Knee (AIK) trials in Australia.

3 Jan 2012

Combination of biomarkers indicates high risk of Alzheimer's in the future

Physician Oskar Hansson and his research group are studying biomarkers - substances present in spinal fluid and linked to Alzheimer's disease. The group has studied close to 140 people with mild memory impairment, showing that a certain combination of markers (low levels of the substance beta-amyloid and high levels of the substance tau) indicate a high risk of developing Alzheimer's disease in the future.

3 Jan 2012

Positive link between physical activity and academic performance of children

A systematic review of previous studies suggests that there may be a positive relationship between physical activity and the academic performance of children, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

3 Jan 2012